Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
FinELibin ja Elsevierin vuodelle 2026 solmiman sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä.
Huom! Tutkijat voivat julkaista ilman APC-maksua sopimukseen kuuluvissa Freedom-lehdissä FinELibin sivuilla mainituilla ehdoilla 31.12.2026 asti.
Tutkijoille maksuttomien avointen artikkelien määrän arvioitiin loppuvan elokuun loppuun mennessä. Elsevier on poistanut avointen artikkelien kiintiön Freedom-lehdistä. Julkaisemisen ehtoihin ei ole tullut muutoksia.
Under the agreement for 2026 between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access.
Att! Researchers can publish without an APC fee in the Freedom journals covered by the agreement under the conditions stated in FinELib webpages until 31 December 2026.
The number of free open access articles available to researchers had been estimated to run out by the end of August. Elsevier has removed the quota for open access articles. No changes have been made to the publishing conditions.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
FinELibin ja Elsevierin vuodelle 2026 solmiman sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä.
Huom! Tutkijat voivat julkaista ilman APC-maksua sopimukseen kuuluvissa Freedom-lehdissä FinELibin sivuilla mainituilla ehdoilla 31.12.2026 asti.
Tutkijoille maksuttomien avointen artikkelien määrän arvioitiin loppuvan elokuun loppuun mennessä. Elsevier on poistanut avointen artikkelien kiintiön Freedom-lehdistä. Julkaisemisen ehtoihin ei ole tullut muutoksia.
Under the agreement for 2026 between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access.
Att! Researchers can publish without an APC fee in the Freedom journals covered by the agreement under the conditions stated in FinELib webpages until 31 December 2026.
The number of free open access articles available to researchers had been estimated to run out by the end of August. Elsevier has removed the quota for open access articles. No changes have been made to the publishing conditions.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
FinELibin ja Elsevierin vuodelle 2026 solmiman sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä.
Huom! Tutkijat voivat julkaista ilman APC-maksua sopimukseen kuuluvissa Freedom-lehdissä FinELibin sivuilla mainituilla ehdoilla 31.12.2026 asti.
Tutkijoille maksuttomien avointen artikkelien määrän arvioitiin loppuvan elokuun loppuun mennessä. Elsevier on poistanut avointen artikkelien kiintiön Freedom-lehdistä. Julkaisemisen ehtoihin ei ole tullut muutoksia.
Under the agreement for 2026 between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access.
Att! Researchers can publish without an APC fee in the Freedom journals covered by the agreement under the conditions stated in FinELib webpages until 31 December 2026.
The number of free open access articles available to researchers had been estimated to run out by the end of August. Elsevier has removed the quota for open access articles. No changes have been made to the publishing conditions.
Psychosomatics has been dedicated to helping its readers achieve excellence in the clinical care of patients with medical and psychiatric comorbidity. With the recent certification of psychosomatic medicine as a recognized subspecialty by the American Board of Psychiatry and Neurology, more readers are turning to the pages of Psychosomatics for its peer-reviewed articles and research reports on everything from the latest advances in drug therapy to psychosocial treatments for medical disorders. Crucial knowledge for all practitioners regularly appears in a column detailing the interactions occurring when medical and psychiatric conditions are treated with multiple medications. Other features include concisely written case reports, perspectives on emerging trends in the field, book reviews, and letters.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
The Journal of the Academy of Nutrition and Dietetics is the premier source for the practice and science of food, nutrition, and dietetics. The monthly, peer-reviewed journal presents original articles prepared by scholars and practitioners and is the most widely read professional publication in the field. The Journal focuses on advancing professional knowledge across the range of research and practice issues such as: nutritional science, medical nutrition therapy, public health nutrition, food science and biotechnology, foodservice systems, leadership and management, and dietetics education.
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
FinELibin ja Elsevierin vuodelle 2026 solmiman sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä.
Huom! Tutkijat voivat julkaista ilman APC-maksua sopimukseen kuuluvissa Freedom-lehdissä FinELibin sivuilla mainituilla ehdoilla 31.12.2026 asti.
Tutkijoille maksuttomien avointen artikkelien määrän arvioitiin loppuvan elokuun loppuun mennessä. Elsevier on poistanut avointen artikkelien kiintiön Freedom-lehdistä. Julkaisemisen ehtoihin ei ole tullut muutoksia.
Under the agreement for 2026 between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access.
Att! Researchers can publish without an APC fee in the Freedom journals covered by the agreement under the conditions stated in FinELib webpages until 31 December 2026.
The number of free open access articles available to researchers had been estimated to run out by the end of August. Elsevier has removed the quota for open access articles. No changes have been made to the publishing conditions.

